The International Society of Pharmacovigilance (ISoP) is pleased to highlight an important pharmacovigilance and risk management session taking place during the DIA 2026 Global Annual Meeting in Philadelphia, USA.
Featured Session
#445: Tailoring Risk Minimisation Activities to Special Populations Locally: Patient Needs, Digitalisation, Global Learning
📅 Date: Monday, 15 June 2026
🕓 Time: 16:00–17:00 (EDT)
📍 DIA 2026 Global Annual Meeting, Philadelphia, USA (diaglobal.org)
This session will explore how risk minimisation activities can be adapted to meet the needs of diverse patient populations while leveraging digital innovation and global learning. The discussion aligns closely with current priorities in pharmacovigilance, including patient-centred approaches, measuring the effectiveness of risk minimisation measures, and tailoring safety strategies for special populations. (diaglobal.org)
Why Attend?
As healthcare systems become increasingly interconnected and patient populations more diverse, there is growing recognition that a “one-size-fits-all” approach to risk minimisation may not always achieve the desired outcomes. This session will examine:
- How patient needs can inform local risk minimisation strategies.
- The role of digital technologies in supporting effective risk communication and implementation.
- Lessons learned from global experience and how they can be applied across regions and healthcare settings.
- Approaches to improving the effectiveness of risk management activities for special and underrepresented populations. (diaglobal.org)
Relevance to ISoP Members
The session sits within DIA’s Clinical Safety, Pharmacovigilance and Risk Management Track, which focuses on advancing patient safety through innovative pharmacovigilance practices, patient engagement, emerging technologies, and evidence-based risk management. Topics include special populations, measuring the impact of risk minimisation measures, and AI-enabled safety analytics. (diaglobal.org)
These themes are highly relevant to ISoP’s mission of promoting the safe and effective use of medicines worldwide and advancing the science and practice of pharmacovigilance.
About DIA 2026
The DIA 2026 Global Annual Meeting will be held from 14–18 June 2026 in Philadelphia and brings together regulators, industry, academia, healthcare professionals, and patient representatives to discuss the latest developments in healthcare product development, regulatory science, and patient safety. (diaglobal.org)
ISoP members attending DIA 2026 are encouraged to participate in this session and engage in the discussion on how risk minimisation strategies can be better tailored to the needs of patients around the world.
For further information and to view the full DIA 2026 programme, please visit:
DIA 2026 Global Annual Meeting Agenda
We look forward to seeing many ISoP members participate in this important discussion.
